E-Learning

3 Reasons to Sell CAKE and 1 Stock to Buy Instead

Over the past six months, The Cheesecake Factory has been a great trade, beating the S&P 500 by 28.4%. Its stock price has climbed to $48.75, representing a healthy 33.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Read more

3 Reasons to Sell BKD and 1 Stock to Buy Instead

Over the last six months, Brookdale’s shares have sunk to $5.81, producing a disappointing 15.9% loss - a stark contrast to the S&P 500’s 5.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Read more

3 Reasons MD is Risky and 1 Stock to Buy Instead

Pediatrix Medical Group has been on fire lately. In the past six months alone, the company’s stock price has rocketed 51.5%, reaching $16 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Read more

3 Reasons CHTR is Risky and 1 Stock to Buy Instead

Charter’s 17.9% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $383.08 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Read more

3 Reasons to Sell EVH and 1 Stock to Buy Instead

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Read more

France's Atos to launch reverse stock split on March 25

Atos said on Friday it is launching a reverse stock split as the French IT group aims to restore investor confidence after completing a financial restructuring plan last year to overcome a crushing debt crisis. The stock split will start on March 25 and will end on April 23, Atos said in a statement. Atos' shares are trading at all-time lows, to about half of a cent, after the company completed a 233-million-euro capital increase last year, causing massive dilution for shareholders.

Read more